Advised Cathay Life Insurance in the sale of limited partner interests in 17 infrastructure funds (US$812 million)
Advised CBC Group in the formation of its fifth USD healthcare fund (US$1.67 billion)
Advised Orchid Asia Group in the formation of Fund VIII (US$1.35 billion)
Advised TPP in the formation of Fund II (over US$2.5 billion)
Advised LYFE Capital in the formation of Fund IV and III (over US$1.55 billion)
Advised a top-tier China Healthcare Manager in the formation of Fund V (US$750 million) and Fund VI (US$2.09 billion)
Advised Hosen Capital in the formation of Fund III (US$800 million)
Advised Jeneration Capital in the formation of Fund II (US$650 million)
Advised Ocean Link in the formation of Fund II (US$580 million)
Represented Kinzon Capital in GP-led RMB to USD redenomination transaction (approx. US$80 million)
Represented Bright VC in GP-led RMB to USD redenomination and stapled transaction
Representing several Asia-based insurance companies in numerous investments in various private equity funds
